ELAD Artificial Liver: Phase I/II data; Phase II

An open-label Phase I/II trial in 24 patients with late-stage FHF or primary graft non-function showed that 80% (12/15) of ELAD-treated patients bridged to transplant or recovery compared to 56% (5/9)...